FUO and Biopsy-Negative GCA

GCA: A Massively Parallel Model

We had introduced the massively parallel global cellular automata (GCA) model. Parallel algorithms derived from applications can be mapped straight forward onto this model. In this model a cell in the cell field is dynamically connected (access pattern, dynamic neighbourhood) to other cells. The model can be implemented by pointers stored in the cell state. Via these pointers, each cell has rea...

The GCA-w Massively Parallel Model

Negative Biopsy after Referral for Biopsy-Proven Gastric Cancer

BACKGROUND/AIMS Repeat endoscopy with biopsy is often performed in patients with previously diagnosed gastric cancer to determine further treatment plans. However, biopsy results may differ from the original pathologic report. We reviewed patients who had a negative biopsy after referral for gastric cancer. METHODS A total of 116 patients with negative biopsy results after referral for biopsy...

Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group.

Internal medicine wards in all 8 university hospitals in the Netherlands participated in this prospective study of fever of unknown origin (FUO) from January 1992 until January 1994 in order to update information on the spectrum of diseases causing FUO. We used fixed epidemiologic entry criteria to achieve completeness of enrollment and to avoid unintended selection bias. After entry, immunocom...

Clinical Considerations after a Negative Prostate Biopsy

Accurate diagnosis and follow-up of prostate cancer (PCa) remains a challenge and comes at a considerable cost to the US healthcare system. Over one million US men receive a negative biopsy result each year; however, approximately 25% or more may harbor a cancer that was missed on the biopsy. Unfortunately, many men will have a number of repeat biopsies to satisfy the concern for the presence o...